NOVACYT SIGNS ASSAY DEVELOPMENT CONTRACT FOR DIAGNOSIS OF RESPIRATORY INFECTIONS WITH GENEPOC

Further validation of Novacyt’s expertise in developing assays for clinical applications Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC Paris, France and Camberley, UK – 22 March 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its molecular testing division, Primerdesign, has entered into

Visit Page

CHIFFRE D’AFFAIRES 2017 DE NOVACYT

Novacyt revenues full year 2017 PR FR Croissance record du chiffre d’affaires de 35 % Les ventes en Chine dépassent les attentes Double cotation réussie sur l’AIM

Visit Page